European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading

MT Newswires Live05-22 23:06

European equities traded in the US as American depositary receipts were trending slightly higher late Friday morning, edging up 0.11% to 1,880.31 on the S&P Europe Select ADR Index, which has surged 3% for the week so far.

From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and semiconductor company Sequans Communications (SQNS), which climbed 8.1% and 2.7% respectively. They were followed by furniture maker Natuzzi (NTZ) and telecommunications company Ericsson (ERIC), which increased 3.1% and 1.9% respectively.

The decliners from continental Europe were led by oil and gas company Eni (E) and lender Banco Santander (SAN), which dropped 2.3% and 1.6% respectively. They were followed by biopharmaceutical company Grifols (GRFS) and lender Banco Bilbao Vizcaya Argentaria (BBVA), which lost 1.4% and 0.9% respectively.

The gainers from the UK were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Mereo BioPharma (MREO), which advanced 73% and 6.7% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Bicycle Therapeutics (BCYC), which were up 3.6% and 1.1% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and biotech firm Trinity Biotech (TRIB), which fell 3.1% and 2.4% respectively. They were followed by insurance company Prudential (PUK) and pharmaceutical company Silence Therapeutics (SLN), which were down 1.7% and 0.2% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment